Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « evidence »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
every < evidence < evidenced  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 50.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000012 (2020) Seoyoung C. Kim [États-Unis] ; Sebastian Schneeweiss [États-Unis]When Randomized Clinical Trials and Real-World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety.
000014 (2020) Puja Mehta ; Jessica J. MansonWhat Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
000016 (2020) M. SilbersteinVitamin D: A simpler alternative to tocilizumab for trial in COVID-19?
000042 (2020) Prakhar Vijayvargiya [États-Unis] ; Zerelda Esquer Garrigos [États-Unis] ; Natalia E. Castillo Almeida [États-Unis] ; Pooja R. Gurram [États-Unis] ; Ryan W. Stevens [États-Unis] ; Raymund R. Razonable [États-Unis]Treatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)
000048 (2020) Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000061 (2020) Ver Nica Cantarín-Extremera [Espagne] ; María Jiménez-Legido [Espagne] ; Anna Duat-Rodríguez [Espagne] ; Marta García-Fernández [Espagne] ; Nelmar Valentina Ortiz-Cabrera [Espagne] ; María Luz Ruiz-Falc Rojas [Espagne] ; Luis González-Gutiérrez-Solana [Espagne]Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.
000070 (2020) Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte]Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.
000078 (2020) Phulen Sarma ; Manisha Prajapat ; Pramod Avti ; Hardeep Kaur ; Subodh Kumar ; Bikash MedhiTherapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
000083 (2020) Wen Zhang [République populaire de Chine] ; Yan Zhao [République populaire de Chine] ; Fengchun Zhang [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Taisheng Li [République populaire de Chine] ; Zhengyin Liu [République populaire de Chine] ; Jinglan Wang [République populaire de Chine] ; Yan Qin [République populaire de Chine] ; Xuan Zhang [République populaire de Chine] ; Xiaowei Yan [République populaire de Chine] ; Xiaofeng Zeng [République populaire de Chine] ; Shuyang Zhang [République populaire de Chine]The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China
000105 (2020) Peter J. Hotez ; Maria Elena Bottazzi ; David B. CorryThe Potential Role of Th17 Immune Responses in Coronavirus Immunopathology and Vaccine-induced Immune Enhancement
000112 (2020) Sam E. Mansour [États-Unis] ; David J. Browning [États-Unis] ; Keye Wong [États-Unis] ; Harry W. Flynn Jr [États-Unis] ; Abdhish R. Bhavsar [États-Unis]The Evolving Treatment of Diabetic Retinopathy
000114 (2020) Pia M. Vidal [Chili] ; Rodrigo Pacheco [Chili]The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
000119 (2020) Ana Paula Vargas Visentin [Brésil] ; Rafael Colombo [Brésil] ; Ellen Scotton [Brésil] ; Débora Soligo Fracasso [Brésil] ; Adriane Ribeiro Da Rosa [Brésil] ; Catia Santos Branco [Brésil] ; Mirian Salvador [Brésil]Targeting Inflammatory-Mitochondrial Response in Major Depression: Current Evidence and Further Challenges
000150 (2020) Giovanna Garufi [Italie] ; Luisa Carbognin [Italie] ; Armando Orlandi [Italie] ; Giampaolo Tortora [Italie] ; Emilio Bria [Italie]Smoking Habit and Hospitalization for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Related Pneumonia: the unsolved paradox behind the evidence.
000170 (2020) Renba Liang ; Xishan Chen ; Li Chen ; Fangzhu Wan ; Kaihua Chen ; Yongchu Sun ; Xiaodong ZhuSTAT3 signaling in ovarian cancer: a potential therapeutic target
000180 (2020) Emily Yi-Chih Ting ; Albert C. Yang [États-Unis] ; Shih-Jen Tsai [Taïwan]Role of Interleukin-6 in Depressive Disorder
000185 (2020) Yuan-Yuan Wei [République populaire de Chine] ; Rui-Rui Wang [République populaire de Chine] ; Da-Wei Zhang [République populaire de Chine] ; You- Hui Tu [République populaire de Chine] ; Chang- Shan Chen [République populaire de Chine] ; Shuang Ji [République populaire de Chine] ; Chun-Xi Li [République populaire de Chine] ; Xiu-Yong Li [République populaire de Chine] ; Meng-Xi Zhou [République populaire de Chine] ; Wen- Sheng Cao [République populaire de Chine] ; Ming- Feng Han [République populaire de Chine] ; Guang-He Fei [République populaire de Chine]Risk factors for severe COVID-19: evidence from 167 hospitalized patients in Anhui, China
000187 (2020) Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000210 (2020) Thomas Koudstaal ; Karin A. Boomars ; Mirjam KoolPulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: An Immunological Perspective
000217 (2020) Kueiyu Joshua Lin [États-Unis] ; Evan Dvorin [États-Unis] ; Aaron S. Kesselheim [États-Unis]Prescribing systemic steroids for acute respiratory tract infections in United States outpatient settings: A nationwide population-based cohort study
000218 (2020) Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Francesco Caso [Italie] ; Federico Perosa [Italie] ; Fabiola Atzeni [Italie] ; Francesco Paolo Cantatore [Italie] ; Raffaele Scarpa [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie]Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "evidence" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "evidence" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    evidence
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021